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ABSTRACT 
Objective:  The history, diagnosis, and therapy of idiopathic intracranial hypertension (IIH) are reviewed. Theo-
ries of pathogenesis are considered, the clinical presentation is described, and potential diagnostic and thera-
peutic challenges are explored. Keeping in view all these things efficacy of L.P Shunt is observed. 
Material and Methods:  A total of 35 patients were diagnosed as IHH according to the Modified Dandy’s criteria 
in our department from August 2007 to October 2012. An extensive literature review of IIH and related condi-
tions was performed. The history of and rationale for the diagnosis and medical and surgical approaches to tre-
atment are reviewed. Outcome of the patients’ with L.P shunt is observed. 
Study Design:  Prospective and analytic study. 
Results:  LP shunt addresses the cause of both headache and papilloedema more directly by effecting a global 
reduction of intracranial pressure. All patients underwent clinical, imaging, and CSF manometry evaluations. All 
patients showed failure or noncompliance to medical treatment and necessitated placement of an LP shunt. 
Among 35 patients who underwent LP shunt placement for IIH, 14 (40%) patients had severe and fulminant 
opening CSF pressures with values of more than 400 mm H2O. while in 21 (60%) patients opening CSF pressure 
was 260 to 400 mm H2O. symptoms of headache and papilloedema and visual obscuration improved in most of 
the patients. Shunt complications included two (0.7%) cases of shunt dislodgement and one (0.35%) case of shunt 
over drainage. Multiple potential contributing causes of intracranial hypertension must be excluded. On the basis 
of the advantages and disadvantages of different treatment modalities, we found L.P Shunt to be more effective 
and advantageous. 
Conclusion:  Idiopathic intracranial hypertension is the diagnosis of exclusion. Medical therapy has a very little 
role in relieving signs and symptoms of this disease. L.P Shunt should be the treatment option in IIH. 
Key Words:  Lumboperitoneal shunt, Headache, Idiopathic intracranial hypertension, Papilloedema. 
Abbreviations:  IIH = Idiopathic Intracranial Hypertension, LP = Lumboperitoneal, CSF = Cerebrospinal fluid, 
ICP = Intracranial pressure, H2O = Water. 
 
INTRODUCTION 
Idiopathic intracranial hypertension (IIH) was origin-
nally described by Quincke in 1893. He reported seve-
ral cases of increased intracranial pressure (ICP) with-
out a brain tumor. Nonne described the syndrome 
more fully and coined the term pseudotumor cerebri in 
1904. In 1937, Dandy described 22 patients with incre-
ased ICP without brain tumor. In 1955, Foley attem-
pted to simplify the nomenclature by describing this 
condition as benign intracranial hypertension. How-
ever, in view of the potential for devastating loss of 
vision associated with papilloedema, Corbett and Tho-
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mpson removed the adjective ―benign‖ and substituted 
―idiopathic.‖ 
 Idiopathic intracranial hypertension denotes the 
condition of increased ICP without an obvious under-
lying brain pathological condition (and no evidence of 
venous thrombosis). 
 The diagnosis of the idiopathic intra cranial hyper-
tension is based on the Dandy’s criteria being modi-
fied by Smith in 1985. Dandy originally described the 
presence of symptoms of increased ICP, documented 
cerebrospinal fluid (CSF) pressures of 250 to 550 mm 
H2O (18.11 to 39.85 mmHg) with normal CSF find-
ings and excluded the possibility of brain tumors with 
ventriculography. 
 
Modified Dandy Criteria for Idiopathic Intracranial 
Hypertension 
Symptoms of increased ICP (headaches, nausea, vomi-
ting, transient visual obscurations, or papilloedema). 
No localizing findings in neurological examinations (ex-
cept for false localizing signs such as abducens or facial 
palsies) Awake and alert patient. 
Normal CT / MRI findings without evidence of dural 
sinus Thrombosis. 
ICP of 250 mm H2O (18.11 mmHg) with normal cere-
brospinal fluid cytological and chemical findings. 
No other cause of increased ICP found 
Adapted from Digre KB, Corbett JJ: Idiopathic intra-
cranial hypertension (pseudotumor cerebri): A reapprai-
sal. Neurology 7:2–67, 2001. 
 
 1 mmHg = 13.8 mmH2O. Shunt surgery (V.P. 
Shunt) was introduced in 1949. L.P. Shunt for IIH was 
introduced in 1971. 
 
Incidence 
The prevalence is approximately 1 case / 100,000 
women but increases to 13 cases / 100,000 women of 
ages 20 to 44 years who are 10% above ideal body 
weight and 19 cases / 100,000 women of ages 20 to 44 
years who are obese 20% above ideal body weight. 
 Most studies demonstrated an age of onset bet-
ween 11 and 58 years, with a mean of approximately 
30 years. 
 Men are affected less frequently. The incidence is 
0.3 cases / 100,000 men but increases to 1.5 cases / 
100,000 obese men 20% above ideal body weight. 
Female – to – male ratios are approximately 4.3:1 to 
8:1. 
Pathophysiology 
Mostly unclear. 
Relative resistance to absorption of CSF across ara-
chnoid villi is widely presumed. 
 Other theories support an abnormality in cerebral 
circulation which causes an increase in the brain water 
content which leads to increased ICP resulting in pa-
pilloedema. 
 Disease is most commonly associated with obese 
women. Obesity causes increase in the intra-abdominal 
pressure increasing cardiac filling pressure leading to 
impeded venous return from brain to heart which pro-
duces an increased venous pressure and increased 
intracranial pressure. 
 
Clinical Presentation 
Headache and visual obscuration is the most common 
symptoms. Sometimes the patients have pulsatile tin-
nitus and numbness can also occur. Papilledema is a 
criterion for the condition, is observed for virtually all 
patients with IIH and is the most important sign. 
Abducens palsy, a false localizing sign thought to be 
attributable to traction of the VI
th
 cranial nerve result-
ing from intracranial hypertension, is observed in 
approximately 20% of cases. Patients with IIH have 
traditionally been thought to have slit ventricles, but a 
review of computed tomographic findings with IIH de-
monstrated slit – like ventricles for only 11%; enlarged 
optic nerve sheaths (47%) and empty sella syndrome 
(46%) were more common. On L. P manometry, pres-
sure of greater than 250 mm H2O (18.11 mmHg), mea-
sured with the patient relaxed, in the lateral decubitus 
position, is one of the modified Dandy criteria. The 
most significant sequela of IIH is blindness or per-
manent visual impairment caused by prolonged papil-
loedema with secondary optic atrophy. Because visual 
loss is usually insidious, patients may be nonchalant 
regarding vision testing and follow-up monitoring un-
til irreversible damage to the optic nerve occurs. 
 
Treatment 
The treatment goal is to preserve optic nerve function 
while managing the increased ICP. Treatment indi-
cated when there is severe intractable headache and 
evidence of progressive decrease in visual acuity. Ces-
sation of the causative agents, weight reduction, carbo-
nic anhydrase inhibitors and corticosteroids are the 
main stay of the medical treatment. 
 Surgical options include venticulo peritoneal shu-
nt, lumbo peritoneal shunt and optic nerve sheath fene-
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stration. 
 Anecdotal reports of success suggested that it was 
a curative procedure, as long as the shunt functioned 
properly. A multicenter review of the outcomes of shu-
nting showed that the vision of most patients either 
improved or stabilized postoperatively. The finding 
that many optic nerve sheath fenestrations fail within 1 
year, as well as mounting evidence of serious compli-
cations has proved LP shunting as the favored surgical 
treatment option. 
 
MATERIAL AND METHODS 
A total of 35 patients were diagnosed as IHH accord-
ing to the Modified Dandy’s criteria in our department 
from August 2007 to October 2012. An extensive lite-
rature review of IIH and related conditions was perfor-
med. The history of and rationale for the diagnosis and 
medical and surgical approaches to treatment are revi-
ewed. Outcome of the patients’ with L.P shunt is obse-
rved. 
 
Surgical Procedure 
The patient is placed in the lateral position with his/her 
knees bend. The surgery is performed in G.A. Under 
complete aseptic measure a 3-4 cm skin incision is 
given between the spinous process of L3 – L4 or L4 – 
L5. A Tuohy needle can be inserted in the midline after 
the paraspinal incision. The head end of the table is 
temporarily elevated 30° to increase the pressure in the 
lumbar subarachnoid space. A fourteen-gauge Tuohy 
needle is inserted into the lumbar subarachnoid space 
with the bevel – pointed cephalad (Fig. 1, 2). The lum-
bar end of the catheter is passed through the Tuohy 
needle. The operating table is tilted back to the normal 
position. The needle is withdrawn over the catheter. A 
small incision is made in the flank and the subcutane-
ous catheter passer with the obturator in place is pas-
sed through the flank incision. The obturator is remo-
ved and the distal end of the peritoneal catheter is in-
serted into the lumbar opening of the subcutaneous 
catheter passer. The subcutaneous catheter passer is 
withdrawn over the catheter leaving the flank portion 
in place. A small skin incision is made 2 cm below the 
umbilicus and 3 cm away from the midline. The sub-
cutaneous catheter passer with the obturator in place is 
inserted from the abdominal incision to the flank incis-
ion. The obturator is removed and the peritoneal end is 
inserted into the flank opening of the catheter passer. 
The catheter is passed through the passer. The catheter 
is inserted into the peritoneal cavity under direct vis-
ion. The chamber is anchored by stitching it to prevent 
shunt dislodgement. After homeostasis all the wounds 
are closed in layers and aseptic bandaging is done. 
 
 
 
Fig. 1: Steps of Operative Procedures Lateral Posterior of 
patient lumber end of catheter inserted it L3-4 
posterior. 
 
 
 
Fig. 2: Steps of Operative Procedures Lateral Posterior of 
patient lumber end of catheter inserted it L3-4 
posterior. 
 
RESULTS 
Sex Incidence 
This study was descriptive study in which we included 
35 patients, 30 females and 5 males. 
 
Age Incidence 
Age ranging from 20 years to 45 years who presented
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to us from the outdoor department of Lahore General 
Hospital, Lahore from August 2007 to October 2012. 
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Fig. 3:  No. of Patients with Different Age Range. 
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Fig. 4:  Sex Incidence. 
 
 In all of our patients Fundoscopy was done which 
revealed papilloedema in all the 35 (100%) patients, 
L.P manometry revealed 16 (40%) patients had severe 
and fulminant opening CSF pressures with values of 
more than 400 mmH2O. while in 21 (60%) patients 
opening CSF pressure was 260 to 400 mmH2O. At the 
same time CSF cytology and biochemistry was done 
revealing normal reports (Table 1). 
 C.T Scan brain plain and with I/V contrast, MRI 
brain plain and with I/V contrast and MRV of all the 
patients were performed. Most of the CT scans brain 
and MRI brain revealed normal study except in 16 
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Fig. 5:  No. of Patients visited in Different Years. 
 
 
 
Fig. 6a:  Pre- operative fundus (Papilloedema). 
 
 
 
Fig. 6b:  Post-operative fundus (after 2 months). 
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Table 1:  CSF Pressure and Number of Patients. 
 
CSF Pressure Patients 
mmH2O mmHg No Percentage 
More than 400 29 16   40 
260 – 400 18.8 – 29 21   60 
Total  35 100 
 
1 mmHg = 13.8 mmH2O 
 
 
 
Fig. 7a:  C.T Scan brain plain (Slit like ventricles). 
 
(40%) patients showing slit – like ventricles. MRV of 
all the patients showed that the venous sinuses were 
patent. 
Obesity was seen in 28 (80%) patients. 
 
 
Fig. 7b:  M.R.V showing patent dural sinuses. 
 
 Initially all the patients were offered medical 
treatment but due to failure of the medical treatment, 
they underwent L.P Shunt procedure. 
 Treatment policy of idiopathic intracranial hyper-
tension, include neuroimaging (CT Scan Brain, MRI 
Brain, MRV), L.P manometery in lateral decubitus 
position, introduction of touhy needle into L3 – L4 
space, catheter is directed upwards, CSF cytology is 
sent, mostly L.P Shunt is done via 2 incisions, post 
operative X-Rays is done in these patients. 
 Post operatively, X-Ray abdomen lateral and A.P 
views were performed to ensure the proper placement 
of the L.P shunt. 
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OUTCOME 
With the L.P shunt in all the 35 (100%) patients, head-
ache was relieved. In 28 (80%) patients the visual 
symptoms resolved completely while 7 (20%) of the 
patients there was only partial improvement. The vis-
ual improvement in our patients depended upon the 
pre operative visual status of the patients, as some pat-
ients presented to us late. 
 Shunt complications included two (0.7%) cases of 
shunt dislodgement and one (0.35%) case of shunt 
over drainage. 
 
DISCUSSION 
Two goals must be considered when managing pati-
ents with idiopathic intracranial hypertension: prevent-
ion of visual loss and resolution of symptoms. Pre-
sence of severe visual loss (20/40 or worse) in one or 
both eyes at time of initial examination is one of the 
indications for surgery. In one of the case report Le-
vent Sinan Bir et al visual acuity was 20/100 in the 
right eye and 5/100 in the left eye on admission. It is 
estimated that up to 17 percent of patients with IIH 
will progress to develop permanent visual loss. The 
final visual outcome in fulminant IIH is variable but, 
up to half of the patients, could become totally blind. 
Mensah et al. reported that patients with marked visual 
field constriction and severe visual acuity loss at the 
time of onset of the IIH showed only partial response 
to therapy with diuretics and steroids and these pati-
ents have suffered clinically malignant course with 
rapid progression to near blindness. Malomo et al. 
reported a case with a 4 – week history of persistent of 
IHH with visual loss and deafness that had a good res-
ponse to the nonoperative treatments; however, Kidron 
and Pomeranz reported two cases with malignant IHH 
and one of these patients underwent lumboperitoneal 
shunt operation. In fact, it is not well known about 
malignant form of IHH, and there is no obvious expla-
nation of the disastrous outcome in these patients, but, 
in agreement with occasional reports in the literature, 
it is strongly suggested not to squander time so as to 
protect the patient’s visual acuity. 
 While in our study In 28 (80%) patients the visual 
symptoms resolved completely while 7 (20%) of the 
patients there was only partial improvement, although 
in some patients presence of visual symptoms were for 
a longer period of time, even than the result visual 
improvement after L. P. Shunt in our study is very 
much comparable to the international studies. 
 At present, no prospective, randomized, clinical
trials have compared the outcomes of these different 
therapies. Therefore, no procedure has been proven to 
be most efficacious. 
 Skau M et al, showed that optic nerve fenestration 
may prevent further visual loss, and has also helped 
relieve headache in up to one thirds of patients while 
with L.P Shunt there was improvement in headache in 
more than two third of the patients. Where as in our 
study 100% of the patients got relief from the head-
ache symptoms. However, up to 33% of patients recei-
ving fenestration who demonstrates visual improve-
ment initially may manifest later deterioration in visual 
function. 
 In a study by Spoor TC et al, it was shown that 
cerebrospinal fluid shunting may be beneficial in 
treating acute visual loss and symptoms of intractable 
headache. Although considered the superior treatment 
for headache relief, shunting also significantly impro-
ved or stabilized visual function (Burgett RA et al). 
The same is proved in our study. Baker et al. recom-
mended shunting for intractable headaches in the set-
ting of progressive visual loss. 
 So, we recommend L.P Shunt to be performed as 
early as the patient is diagnosed. 
 
CONCLUSION 
Idiopathic intracranial hypertension is the diagnosis of 
exclusion. Medical therapy has a very little role in reli-
eving signs and symptoms of this disease. L.P Shunt 
should be the treatment option in IIH. 
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